A yeast-derived postbiotic (from Saccharomyces cerevisiae) has been demonstrated to benefit seasonal allergies and immune conditions in humans and in preliminary animal studies [41,42], as well as to improve serum IgA levels in dogs [43] (low IgA levels are commonly associated with atopy [44]). This evidence concerns the gene CD79A and allergic disease.